Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This is rare and usually only for safety reasons
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
Essential elements of our treatment protocol include: Comprehensive medical evaluation before treatment initiation Regular monitoring of therapeutic response and metabolic parameters Ongoing assessment of muscle mass and body composition Integration with personalised wellness and nutrition planning Looking Forward As medical science continues to evolve, microdosing of GLP-1 agonists represents a promising development in personalised medicine
They may adjust your GLP-1 dose, modify other medications, or, in rare cases, consider discontinuing the GLP-1 agonist if the benefits no longer outweigh the risks
Recovery time, injury prevention, and muscle regeneration arent just luxuries, theyre necessities
